Interestingly, prostate cancer-derived EVs transfer CSF-1, VEGFA, MCP1, RUNX2, and FGF2 transcripts within recipient OBLs, but only CSF-1 content is significantly increased in the recipient cells, suggesting a mechanism controlling the selective use of EVs-cargo molecules in recipient OBLs. This evidence concerns the gene CSF1 and prostate cancer.